Fan Zexin, Wu Chao, Wang Chaobin, Liu Chun, Fang Libo, Ma Lin, Zou Wenlong, Yuan Boyi, Ji Zeyu, Cai Bin, Liu Guangzhi
Department of Neurology, The Second Hospital of Shanxi Medical University, 030001 Taiyuan, Shanxi, China.
Department of Neurology, Beijing Anzhen Hospital, Capital Medical University, 100029 Beijing, China.
Rev Cardiovasc Med. 2024 Jun 14;25(6):215. doi: 10.31083/j.rcm2506215. eCollection 2024 Jun.
Growing evidence suggests that concurrent ischaemic stroke (IS) exacerbates the prognosis of patients with dilated cardiomyopathy (DCM) and that this effect may be further influenced by sex. However, the exact effect of sex remains unclear. This study aimed to explore the effects of the relevant risk factors on the prognosis of patients with DCM and concurrent IS. Considering the sex differences in DCM, this study further investigated the impact of concurrent IS on the prognosis of men and women with DCM.
A total of 632 patients with DCM enrolled between 2016 and 2021 were included in this study. Clinical data were obtained from medical records, and all participants were followed up in the outpatient clinic or by telephone for at least 1 year. A Cox proportional hazards model and Kaplan-Meier curves were used to evaluate the effects of concurrent IS on the prognosis of patients with DCM.
Patients with DCM complicated with IS (DCM-IS) had significantly lower cumulative survival rates than patients with DCM without IS (non-IS) (74.6% vs. 84.2%, = 6.85, = 0.009). Additionally, IS was associated with greater risks of death and heart transplantation (HTx) in men (75.8% vs. 85.1%, = 5.02, = 0.025), but not in women (71.0% vs. 81.5%, = 1.91, = 0.167).
This large-scale multicentre prospective cohort study demonstrated a poorer prognosis in patients with concurrent DCM and IS, particularly among men. Patients with DCM should not be overlooked in IS screening, emphasis should be placed on the occurrence of IS in patients with DCM. Early and proactive secondary prevention of cerebrovascular diseases might improve the prognosis of DCM patients. More intervention studies focusing on men with DCM complicated with IS should be prioritised.
越来越多的证据表明,并发缺血性卒中(IS)会使扩张型心肌病(DCM)患者的预后恶化,且这种影响可能会因性别而进一步受到影响。然而,性别的具体影响仍不明确。本研究旨在探讨相关危险因素对DCM并发IS患者预后的影响。考虑到DCM中的性别差异,本研究进一步调查了并发IS对DCM男性和女性患者预后的影响。
本研究纳入了2016年至2021年间登记的632例DCM患者。临床数据从病历中获取,所有参与者在门诊或通过电话随访至少1年。采用Cox比例风险模型和Kaplan-Meier曲线评估并发IS对DCM患者预后的影响。
DCM并发IS(DCM-IS)患者的累积生存率显著低于无IS的DCM患者(非IS)(74.6%对84.2%,χ² = 6.85,P = 0.009)。此外,IS与男性更高的死亡和心脏移植(HTx)风险相关(75.8%对85.1%,χ² = 5.02,P = 0.025),但与女性无关(71.0%对81.5%,χ² = 1.91,P = 0.167)。
这项大规模多中心前瞻性队列研究表明,DCM并发IS患者的预后较差,尤其是男性。在IS筛查中不应忽视DCM患者,应重视DCM患者中IS的发生。早期积极的脑血管疾病二级预防可能会改善DCM患者的预后。应优先开展更多针对DCM并发IS男性患者的干预研究。